Tumor Mapping in Two Large Multigenerational Families With CYLD Mutations

    November 2009 in “ Archives of Dermatology
    Neil Rajan, J.A.A. Langtry, Alan Ashworth, Catherine Roberts, Peter Chapman, John Burn, Alison H. Trainer
    Image
    Studysummary This study observed that patients with CYLD mutations frequently experienced severe, painful tumors beyond the head and neck, impacting their quality of life, with hormonal factors possibly contributing to tumor development. Our plain-language summary of this paper — not a Tressless recommendation.
    In 2009, researchers studied 34 individuals from two families with CYLD mutations to understand the clinical features of related skin tumors. They found significant variability in symptoms and tumor locations, with an average onset age of 16. The study revealed that CYLD mutations lead to a range of skin tumors, with 50 different mutations identified, mostly at the gene's carboxyl terminus. This variability complicates genetic counseling and prognostication. The term "CYLD cutaneous syndrome" was proposed to encompass the range of associated clinical diagnoses. The study also noted the limited effectiveness of topical aspirin and the potential for treatments targeting the nuclear factor KB pathway, emphasizing the need for further research in this area.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results